All results / Stories

La Jolla-Based Innovus Acquires Texas Firm

La Jolla’s Innovus Pharmaceuticals Inc., a commercial-stage drug company that makes over-the-counter medicine, has acquired Austin, Texas-based Beyond Human for $630,000 in cash.

Organovo Upgrades Over-the-Counter Listing

Organovo Holdings Inc., a San Diego developer and manufacturer of human tissues using three-dimensional bioprinting technology, said the company’s stock will begin trading on the highest over-the-counter marketplace, OTCQX.

Inovio, Vical Study Cancer Treatment in Humans

Two San Diego-based biotechnology companies announced July 18 they started the first human trials to evaluate the safety of targeted cancer therapy delivery in patients with metastatic melanoma.

BIO-TECH--Avanir Eagerly Awaits Over-the-Counter Sales

San Diego-based Avanir Pharmaceuticals said the recent Food and Drug Administration approval for the first over-the-counter herpes drug marks a major milestone for the firm.

Santarus May Find Relief in '08 With Sale of Rights to Heartburn Medicine

San Diego's Santarus Inc. this month added 150 salespeople and said the firm expects to break even in the second half of 2008.

Avanir's Stock Soars on Word of Potential Anthrax Drug

San Diego-based Avanir Pharmaceuticals, best known for its over-the-counter cold sore medication, Abreva, believes it has created a viable drug to protect against a potentially deadly threat , anthrax.

FDA Makes the Right Move

The U.S. Food and Drug Administration has taken a big step forward in ensuring not only the safety of millions of consumers, but also in monitoring the activities of companies manufacturing potentially harmful drugs.

Pharmacy With 'Integrative' Approach Opening in La Jolla

Pharmaca Integrative Pharmacy is set to celebrate its grand opening Sept. 6 at 7650 Girard Ave. in La Jolla.

Charlotte Russe Plans a Comeback, YM Inc. Confirms

Jasna Brtan, vice president of human resources at YM Inc., the Toronto, Canada-based company that acquired Charlotte Russe in March, confirmed the tweet via email.

Tease photo

Hertzog Promoted to COO of Innovative Employee Solutions

Kara Hertzog is a third-generation employee at the San Diego-based payroll and human resources administration company.

Investors Bet on Bioprinting as the Next Big Thing in Medicine

SCIENCE: Organovo Raises Funds to Advance Novel Tissue Technology

Backers stepped up and invested $6.5 million in Organovo Inc.

Tease photo

More Routes for Airport

TRANSPORTATION: International Flights Up

Just last week, the Biden administration announced it would lift travel bans for fully vaccinated international travelers starting in November. This includes visitors from the U.K. and the EU, according to reports.

Tease photo

Kleinfelder Names John A. Murphy CFO, Patrick Schaffner SVP

Civil engineering firm Kleinfelder on Thursday said John A. Murphy has been named chief financial officer and executive vice president and Patrick Schaffner has been named senior vice president and director of human resources.

Tease photo

Companies Envision Canadian Oil Plant

Surge Global Energy Inc. of San Diego is joining forces with Genoil Inc. of Alberta, Canada, to build the first major commercial upgrader in North America.

Entrepreneur Sees Human Memory as The Next Big Thing

After Previous Success, Kanuganti Believes Region Perfect for New Tech Co.

Tease photo


BIOTECH: Bioprinter Aims to Give L’Oreal Tissue for Product Testing

Organovo has landed a research partnership with beauty conglomerate L’Oreal to create 3-D bioprinted human skin to test cosmetics.

Tease photo

Biotechs: Importing Drugs Bad Medicine

Some local life science leaders recently called for Gov. Arnold Schwarzenegger to rethink his proposal to legalize importation of prescription drugs.

Software Captiva gives chase to the 'paper chase'

More and more drug orders were arriving at Prescription Solutions, and the tide of paper flowing through the mail-order pharmacy was only getting stronger.

Week in Review

Cash Offer For Tepnel: Gen-Probe, the San Diego-based maker of test kits used to screen human blood and diagnose diseases, offered to acquire British diagnostics company Tepnel Life Sciences in an all-cash deal valued at $132.2 million.

Execs: U.S. Should Follow Europe's Approach OK'ing New Biologics

A recent survey shows that 44 percent of biotech executives believe the United States should follow the European approach for approving generic biologics.